No phaseStatus unknown
Using telemedicine and new technologies to improve heart failure treatment
Comprehensive Therapeutic Optimization in Heart Failure: Application of New Technologies and Innovations
- Sponsor
- Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo
- Enrolment
- 200 planned
- Conditions
- Heart Failure Cardiovascular Diseases
- Interventions
- This is a prospective, randomized, controlled, pragmatic, multicenter, open-label clinical trial with blinded outcome assessment
- Ages
- adults, older adults
- Registry
- RBR-32w3s4p
Full record on ReBECSource: WHO ICTRP, processed 3 August 2026
Primary outcomes
- The primary outcome is the proportion of participants achieving optimized pharmacological treatment for heart failure with reduced ejection fraction, defined as the use of at least three medication classes recommended by clinical guidelines and achievement of at least 75% of the recommended target d
History
Study completion expected
Last registry update
Started
Registered